This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 May 8;397(10286):1687-1689.

doi: 10.1016/S0140-6736(21)00944-2. Epub 2021 Apr 22.

Cagrilintide plus semaglutide for obesity management

Sara Becerril¹, Gema Frühbeck²

Affiliations

Affiliations

¹ Metabolic Research Laboratory, Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, University of Navarra, IdiSNA, CIBEROBN, 31008 Pamplona, Spain.
² Metabolic Research Laboratory, Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, University of Navarra, IdiSNA, CIBEROBN, 31008 Pamplona, Spain. Electronic address: gfruhbeck@unav.es.

PMID: 33894837
DOI: 10.1016/S0140-6736(21)00944-2

Comment

Cagrilintide plus semaglutide for obesity management

Sara Becerril et al. Lancet. 2021.

. 2021 May 8;397(10286):1687-1689.

doi: 10.1016/S0140-6736(21)00944-2. Epub 2021 Apr 22.

Authors

Sara Becerril¹, Gema Frühbeck²

Affiliations

¹ Metabolic Research Laboratory, Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, University of Navarra, IdiSNA, CIBEROBN, 31008 Pamplona, Spain.
² Metabolic Research Laboratory, Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, University of Navarra, IdiSNA, CIBEROBN, 31008 Pamplona, Spain. Electronic address: gfruhbeck@unav.es.

PMID: 33894837
DOI: 10.1016/S0140-6736(21)00944-2

No abstract available

PubMed Disclaimer

Comment on

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.
Enebo LB, Berthelsen KK, Kankam M, Lund MT, Rubino DM, Satylganova A, Lau DCW. Enebo LB, et al. Lancet. 2021 May 8;397(10286):1736-1748. doi: 10.1016/S0140-6736(21)00845-X. Epub 2021 Apr 22. Lancet. 2021. PMID: 33894838 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations